Ticker Details
IGM Biosciences, Inc.
IPO Date:	September 16, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$76.57M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$1.32 | 4.31%
Avg Daily Range (30 D):	$0.01 | 0.84%
Avg Daily Range (90 D):	$0.03 | 2.21%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	77
Avg Trade Size (Sh.) (30 D):	587
Avg Trade Size (Sh.) (90 D):	340

Institutional Trades
Total Institutional Trades:	723
Avg Institutional Trade:	$1.57M
Avg Institutional Trade (30 D):	$1.22M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.86M
Avg Closing Trade (30 D):	$1.22M
Avg Closing Trade (90 D):	$1.35M
Avg Closing Volume:	56.47K

News

Jul 5, 2025 @ 1:38 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jan 9, 2025 @ 6:00 PM IGM Biosciences Provides Strategic Update on Autoi... Source: N/A

Nov 4, 2024 @ 12:00 PM IGM Biosciences to Present at Three Upcoming Inves... Source: N/A

Sep 18, 2024 @ 3:22 PM Russell 2000 Outpaces S&P 500 As Small Caps Antici... Source: Surbhi Jain

Jul 12, 2024 @ 8:25 PM Russell 2000 Index Notches Strongest Week Of Year,... Source: Piero Cingari, Benzinga Staff Writer

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.89	$1.59	$-.86
Diluted EPS	$-.9	$1.58	$-.86
Revenue	$145.05M	$143.62M	$.5M
Gross Profit
Net Income / Loss	$-53.39M	$97.58M	$-52.89M
Operating Income / Loss	$-61.88M	$96.26M	$-54.78M
Cost of Revenue
Net Cash Flow	$-36.61M	$-6.24M	$10.22M
PE Ratio